← Evidence map

ArticleBiomedicines2026

Very High vs. High Tumor Mutational Burden Across Tumors: Real-World Associations with MSI, Pathway Features, and Immunotherapy Outcomes.

Maria Fernanda Teixeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Very High vs. High Tumor Mutational Burden Across Tumors: Real-World Associations with MSI, Pathway Features, and Immunotherapy Outcomes. | OpenQuestion